Winners & Losers

Friday's Early Winners & Losers

 

Synplicity (SYNP) plummeted more than 27% in after-hours trading Thursday as the Sunnyvale, Calif.-based company guided lower than its previous forecast and below Wall Street expectations as well. The semiconductor-software company now expects revenue of $16.4 million for the Dec. 31, 2006, quarter, down from its previous range of $17.2 million to $17.7 million. Analysts polled by Thomson Financial are seeking $17.5 million.

In addition, the company shaved a penny off the top of its earnings range, now expecting between 6 cents and 7 cents a share. However, this still covers the consensus estimate. Shares were losing $1.73 to $4.60.

Enzon Pharmaceuticals (ENZN) jumped on news that it had submitted an application to the Food and Drug Administration for the development of an antagonist drug that targets multiple cancer processes, including solid tumors, called HIF-1 alpha. The Bridgewater, N.J., company licensed the drug from Denmark-based Santaris Pharma in July 2006. Shares were rising 59 cents, or 7%, to $9.

Learning Tree (LTRE), which develops classroom courses for Internet technology professionals, gained on word of an expected rise in fiscal fourth-quarter results, as well as an earnings restatement that will probably fall in line with previously announced estimates to that effect. Profits from operations are projected at $200,000, which compares with a restated year-ago loss of $800,000, and revenue should rise 6% to $37.7 million. The analyst who follows the company is looking for $38.6 million.

TheStreet Premium Services

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,419.86 1,313.32 2,837.36 16.25
Oil *
103.00
DOWN
160.83
DOWN
19.10
DOWN
33.63
DOWN
1.06
10 Yr
1.62%
SPDR Gold
151.91
-1.28%
-1.43%
-1.17%
-6.12%
Data delayed 20 minutes

Top Stories and Tools

Articles From

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet